LOAMU
ANIP icon

Lombard Odier Asset Management (USA)’s ANI Pharmaceuticals ANIP Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-150,000
Closed -$5.17M – 196
2014
Q2 		$5.17M Sell
150,000
-100,000
-40% -$3.14M 0.27% 100
2014
Q1 		$7.84M Buy
+250,000
New +$6.63M 0.3% 89

Other funds holding ANIP

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s ANIP Position: Q3 2014 in Review

Lombard Odier Asset Management (USA) sold out of ANI Pharmaceuticals (ANIP) in Q3 2014, closing a stake of 150,000 shares — an estimated $5.17M sold.

Lombard Odier Asset Management (USA) first reported a position in ANIP in Q1 2014 and held it in 2 quarters. The position peaked at $7.84M in Q1 2014. 72 funds tracked by Wall St. Rank hold ANIP as of Q3 2014.

  • Lombard Odier Asset Management (USA) reported no remaining ANI Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 150,000 ANI Pharmaceuticals shares in Q3 2014, an estimated $5.17M.
  • Lombard Odier Asset Management (USA) first reported a position in ANI Pharmaceuticals in Q1 2014 and held it in 2 quarters.
  • Lombard Odier Asset Management (USA)'s ANI Pharmaceuticals position peaked at $7.84M in Q1 2014.
  • 72 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2014.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2014, filed 14 Nov 2014.